Indications for Surgical Resection in Patients With Neuroendocrine Tumor Liver Metastases: An Intensive Surgical Experience of a High‐Volume Center

Documenti analoghi

• Current Status of Multidisciplinary Treatment Strategies for Hepatocellular Carcinoma in the Era of Advanced Systemic Therapies
  di: Keiichi Akahoshi, et al.
  Pubblicazione: (2025)
• Response to Letter to the Editor Entitled “Clarifying Treatment Compliance and Future Directions in Perioperative Chemotherapy for Resectable Colorectal Liver Metastases”
  di: Katsunori Shinozaki, et al.
  Pubblicazione: (2025)
• Surgical Resection for Colorectal Liver Metastasis in Elderly Patients Aged ≥ 80: A Retrospective Nationwide Cohort Survey in Japan With Propensity Score Matching
  di: Kiichi Sugimoto, et al.
  Pubblicazione: (2026)
• Preoperative Total Iron‐Binding Capacity Is a Novel Surrogate Marker of Short‐ and Long‐Term Outcomes After Liver Resection for Hepatocellular Carcinoma
  di: Taishi Yamane, et al.
  Pubblicazione: (2026)
• Preoperative Versus Postoperative Chemotherapy With CAPOX Plus Bevacizumab for Resectable Colorectal Liver Metastases: A Randomized Phase II Trial ( HiSCO ‐01)
  di: Yuji Takakura, et al.
  Pubblicazione: (2025)